DavidSHillMD

PubMed

• Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition.
  Armstrong, J.L., Corazzari, M., Martin, S., Pagliarini, V., Falasca, L., Hill, D.S., Ellis, N., Al Sabah, S., Redfern, C.F., Fimia, G.M., Piacentini, M., Lovat, P.E.> ;Clin Cancer Res. 2011 Apr 15
• Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
  Hiscutt, E.L., Hill, D.S., Martin, S., Kerr, R., Harbottle, A., Birch-Machin, M., Redfern, C.F., Fulda, S., Armstrong, J.L., Lovat, P.E.> ;J Invest Dermatol. 2010 Sep
• Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma.
  Hill, D.S., Martin, S., Armstrong, J.L., Flockhart, R., Tonison, J.J., Simpson, D.G., Birch-Machin, M.A., Redfern, C.F., Lovat, P.E.> ;Clin Cancer Res. 2009-02-15
• Targeting GRP78 to enhance melanoma cell death.
  Martin, S., Hill, D. S., Paton, J. C., Paton, A. W., Birch-Machin, M. A., Lovat, P. E., Redfern, C. P.> ;Pigment Cell Melanoma Res. 2010 Oct
• Join now to see all